217 related articles for article (PubMed ID: 33530141)
1. Effect of myocardial dysfunction in cardiac morbidity and all cause mortality in childhood cancer subjects treated with anthracycline therapy.
Toro-Salazar OH; Gillan E; Ferranti J; Orsey A; Rubin K; Upadhyay S; Mazur W; Hor KN
Cardiooncology; 2015 Nov; 1(1):1. PubMed ID: 33530141
[TBL] [Abstract][Full Text] [Related]
2. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
Sieswerda E; van Dalen EC; Postma A; Cheuk DK; Caron HN; Kremer LC
Cochrane Database Syst Rev; 2011 Sep; (9):CD008011. PubMed ID: 21901716
[TBL] [Abstract][Full Text] [Related]
3. Exposure to anthracyclines during childhood causes cardiac injury.
Lipshultz SE
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
[TBL] [Abstract][Full Text] [Related]
4. Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management.
Iarussi D; Indolfi P; Casale F; Martino V; Di Tullio MT; Calabrò R
Paediatr Drugs; 2005; 7(2):67-76. PubMed ID: 15871628
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Surveillance for Early Detection of Late Subclinical Cardiac Dysfunction in Childhood Cancer Survivors After Anthracycline Therapy.
Sofia R; Melita V; De Vita A; Ruggiero A; Romano A; Attinà G; Birritella L; Lamendola P; Lombardo A; Lanza GA; Delogu AB
Front Oncol; 2021; 11():624057. PubMed ID: 34055601
[TBL] [Abstract][Full Text] [Related]
6. Anthracycline-induced cardiotoxicity in patients with paediatric bone sarcoma and soft tissue sarcoma.
Bini I; Asaftei SD; Riggi C; Tirtei E; Manicone R; Biasin E; Basso ME; Agnoletti G; Fagioli F
Cardiol Young; 2017 Nov; 27(9):1815-1822. PubMed ID: 28780919
[TBL] [Abstract][Full Text] [Related]
7. Subclinical Cardiac Dysfunction in Childhood Cancer Survivors on 10-Years Follow-Up Correlates With Cumulative Anthracycline Dose and Is Best Detected by Cardiopulmonary Exercise Testing, Circulating Serum Biomarker, Speckle Tracking Echocardiography, and Tissue Doppler Imaging.
Wolf CM; Reiner B; Kühn A; Hager A; Müller J; Meierhofer C; Oberhoffer R; Ewert P; Schmid I; Weil J
Front Pediatr; 2020; 8():123. PubMed ID: 32296665
[No Abstract] [Full Text] [Related]
8. Anthracycline-induced cardiotoxicity.
Shan K; Lincoff AM; Young JB
Ann Intern Med; 1996 Jul; 125(1):47-58. PubMed ID: 8644988
[TBL] [Abstract][Full Text] [Related]
9. Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.
Leger K; Slone T; Lemler M; Leonard D; Cochran C; Bowman WP; Bashore L; Winick N
Pediatr Blood Cancer; 2015 Jan; 62(1):123-7. PubMed ID: 25176022
[TBL] [Abstract][Full Text] [Related]
10. Cardiac complications in childhood cancer survivors treated with anthracyclines.
Franco VI; Lipshultz SE
Cardiol Young; 2015 Aug; 25 Suppl 2():107-16. PubMed ID: 26377717
[TBL] [Abstract][Full Text] [Related]
11. Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.
Skitch A; Mital S; Mertens L; Liu P; Kantor P; Grosse-Wortmann L; Manlhiot C; Greenberg M; Nathan PC
BMC Cancer; 2017 Aug; 17(1):519. PubMed ID: 28774277
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML.
Creutzig U; Diekamp S; Zimmermann M; Reinhardt D
Pediatr Blood Cancer; 2007 Jun; 48(7):651-62. PubMed ID: 17183582
[TBL] [Abstract][Full Text] [Related]
13. Cardiac toxicity after anthracycline chemotherapy in childhood.
Iarussi D; Indolfi P; Galderisi M; Bossone E
Herz; 2000 Nov; 25(7):676-88. PubMed ID: 11141677
[TBL] [Abstract][Full Text] [Related]
14. Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention.
Henriksen PA
Heart; 2018 Jun; 104(12):971-977. PubMed ID: 29217634
[TBL] [Abstract][Full Text] [Related]
15. Occult cardiotoxicity in childhood cancer survivors exposed to anthracycline therapy.
Toro-Salazar OH; Gillan E; O'Loughlin MT; Burke GS; Ferranti J; Stainsby J; Liang B; Mazur W; Raman SV; Hor KN
Circ Cardiovasc Imaging; 2013 Nov; 6(6):873-80. PubMed ID: 24097420
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of anthracycline cardiotoxicity in children and adults.
Grenier MA; Lipshultz SE
Semin Oncol; 1998 Aug; 25(4 Suppl 10):72-85. PubMed ID: 9768828
[TBL] [Abstract][Full Text] [Related]
17. Echocardiographic Assessment of Cardiac Function in Pediatric Survivors of Anthracycline-Treated Childhood Cancer.
Slieker MG; Fackoury C; Slorach C; Hui W; Friedberg MK; Fan CS; Manlhiot C; Dillenburg R; Kantor P; Mital S; Liu P; Nathan PC; Mertens L
Circ Cardiovasc Imaging; 2019 Dec; 12(12):e008869. PubMed ID: 31826678
[TBL] [Abstract][Full Text] [Related]
18. Tissue Doppler Imaging and Focal, Late-Onset Anthracycline-Induced Cardiovascular Disease in Long Term Survivors of Childhood Cancer: A Research Article.
Rajapreyar P; Lorenzana A; Prabhu A; Szpunar S; Anne P
J Clin Diagn Res; 2016 Aug; 10(8):SC01-4. PubMed ID: 27656519
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology.
Bu'Lock FA; Mott MG; Oakhill A; Martin RP
Br Heart J; 1995 Apr; 73(4):340-50. PubMed ID: 7756067
[TBL] [Abstract][Full Text] [Related]
20. Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclines.
Toro-Salazar OH; Lee JH; Zellars KN; Perreault PE; Mason KC; Wang Z; Hor KN; Gillan E; Zeiss CJ; Gatti DM; Davey BT; Kutty S; Liang BT; Spinale FG
Cardiooncology; 2018; 4():. PubMed ID: 29900007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
